
Research advances in blood cancer treatment enhance donor matching and reduce graft-vs-host disease, improving access to life-saving transplants for diverse patients.
Steven Devine, MD, is the chief medical officer at NMDP and senior scientific director at the Center for International Blood and Marrow Transplant Research (CIBMTR).

Research advances in blood cancer treatment enhance donor matching and reduce graft-vs-host disease, improving access to life-saving transplants for diverse patients.

Published: September 3rd 2025 | Updated: